Demant
Health Care Equipment
Denmark
ESRS disclosure: ESRS E1 \ DR E1-1 \ Paragraph 16 c
Tags Tree
Selected: 0
No matching results found.
- Provide a detailed account of your organization's significant operational and capital expenditures necessary for the execution of your climate change mitigation transition plan, as outlined in Disclosure Requirement E1-1. This should include an explanation and quantification of investments and funding, referencing the key performance indicators of taxonomy-aligned capital expenditures, and, where applicable, the capital expenditure plans disclosed in accordance with Commission Delegated Regulation (EU) 2021/2178.
-
Question Id: E1-1_04
The financial resources required for the implementation of the decarbonisation levers and their relation to the financial statements are yet to be determined, as this depends on further defining the decarbonisation levers and their mitigation actions.
Report Date: 4Q2024Relevance: 30%
- Has your company established targets for reducing greenhouse gas emissions, specifically in terms of Scope 3 emissions, and if so, what is the percentage reduction relative to the emissions of the base year?
-
Question Id: E1-4_16
Demant commits to reducing absolute scope 3 GHG emissions by 46% by 2030 from a 2019 baseline year. Long-term targets include reducing absolute scope 3 GHG emissions by 90% by 2050 from a 2019 baseline year.
Report Date: 4Q2024Relevance: 100%